Phenex Pharmaceuticals AG
3 clinical trials · Sponsor
◉ Watch Phenex Pharmaceuticals AG
| Record | Firm | Date |
|---|---|---|
| Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients (NCT01999101) | Phenex Pharmaceuticals AG | 2013-10-01 |
| Multiple Ascending Oral Dose Phase I Study With Px-102 (NCT01998672) | Phenex Pharmaceuticals AG | 2012-02-01 |
| Single Ascending Oral Dose Phase I Study With Px-102 (NCT01998659) | Phenex Pharmaceuticals AG | 2011-09-01 |
Track Phenex Pharmaceuticals AG automatically
Every clearance here is in the API, with alerts when new ones post.